Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study

Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study

We discuss results of ORIGIN, a multicenter parallel groups study for efficiency assessment of insulin glargin against polyunsaturatedomega-3 fatty acids or placebo regarding cardiovascular and/or mortality risk reduction in patients with impaired fasting glycemia,impaired glucose tolerance or type...

Full description

Bibliographic Details
Main Authors:	Elena Valer'evna Biryukova, Alexander Sergeevich Ametov, Mikhail Borisovich Antsiferov, Alsu Gafurovna Zalevskaya, Galina Afanas'evna Mel'nichenko, Ashot Musaelovich Mkrtumyan, Marina Vladimirovna Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2012-09-01
Series:	Сахарный диабет
Subjects:	prediabetes diabetes mellitus hypoglycemia oncology onsulin glargin origin study
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6092

Similar Items

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
by: Vadim Valer'evich Klimontov, et al.
Published: (2014-12-01)

Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?
by: Rebecca Ohman‐Hanson, et al.
Published: (2024-08-01)

On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01)

Ispol'zovanie inkretinov v lecheniisakharnogo diabeta 2 tipa - vcherashnyaya mechta,blizkaya k real'nosti segodnya
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2006-06-01)

Osobennosti sakharnogo diabeta v pozhilom vozraste i printsipy terapii
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2005-12-01)

Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study
by: Toshitaka Sawamura, et al.
Published: (2024-03-01)

Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
by: Eman N. Alhmoud, et al.
Published: (2024-01-01)

Molekulyarno-geneticheskie osobennosti, kharakter metabolizma glyukozy i funktsiya endoteliya u bol'nykh metabolicheskim sindromom russkoy populyatsii
by: Ashot Musaelovich Mkrtumyan, et al.
Published: (2008-12-01)

rDNA insulin glargine U300 – a critical appraisal
by: Wang F, et al.
Published: (2016-12-01)

Individualisation of basal insulin therapy of type 2 diabetes: evidence from large randomized controlled trials
by: S. V. Nedogoda, et al.
Published: (2023-01-01)

Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration
by: Samantha Walczuk, et al.
Published: (2024-03-01)

Real World Effectiveness of fixed combination of glargine 100 U/ml and lixisenatide therapy in outpatients with Type 2 Diabetes: A Retrospective Cohort Study SOLO
by: M. B. Antsiferov, et al.
Published: (2022-05-01)

Sovremennye rekomendatsii po ispol'zovaniyu zamestitel'noy gormonal'noy terapii u zhenshchin v menopauze
by: Olga Rafael'evna Grigoryan, et al.
Published: (2004-12-01)

Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)
by: Marina Vladimirovna Shestakova, et al.
Published: (2010-03-01)

Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations
by: L. N. Shitov, et al.
Published: (2019-04-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes
by: Patricia Medici Dualib, et al.
Published: (2024-07-01)

DIABETIChESKAYa RETINOPATIYa ? PRIChINA SLEPOTY I INVALIDNOSTI
by: E S Skorobogatova, et al.
Published: (2003-06-01)

Long-acting insulin analogue in the treatment of type 2 diabetes mellitus: emphasis on proven efficacy and safety
by: E. V. Biryukova, et al.
Published: (2021-09-01)

Pharmacokinetic and pharmacodynamic similarity evaluation between an insulin glargine biosimilar product and Lantus® in healthy subjects: Pharmacokinetic parameters of both parent insulin glargine and M1 were used as endpoints
by: Yiya Wang, et al.
Published: (2022-08-01)

Development and Validation of Approach for the Detection of Neutralizing Antibodies Against Insulin (Glargine) in Human Blood Plasma
by: N. B. Abramenko, et al.
Published: (2019-09-01)

Treatment of Abnormal Glucose Regulation and Huge Ovarian Cysts with High Dose Insulin Glargine in an Infant with Leprechaunism - Case Report
by: Ayşe Yasemin Çelik, et al.
Published: (2010-12-01)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
by: Lau IT, et al.
Published: (2017-06-01)

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
by: Thomann R, et al.
Published: (2020-07-01)

Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study
by: Nader ND, et al.
Published: (2020-03-01)

The Modified Recombinant Proinsulin: A Simple and Efficient Way to Produce Insulin Glargine in E. coli
by: Seyyedeh khadijeh Hosseini oula, et al.
Published: (2021-08-01)

Clinical experience in using long-acting human insulin Glargine 300 U/ml in the practice of an endocrinologist
by: O. A. Guseva, et al.
Published: (2018-04-01)

Leading causes of death and concomitant pathology in patients with type 2 diabetes mellitus according to autopsy data
by: Anna Leont'evna Terekhova, et al.
Published: (2011-12-01)

Diabetes mellitus and driving a motor vehicle
by: Mariya Nikolaevna Dunicheva, et al.
Published: (2016-11-01)

A comparative evaluation of bioequivalence of Gan & Lee glargine U300 and Toujeo® in Chinese healthy male participants
by: Xiaoli Li, et al.
Published: (2024-08-01)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
by: Natalya Nikitichna Volevodz, et al.
Published: (2013-03-01)

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
by: Liu D, et al.
Published: (2021-04-01)

Efficacy of Glargine Insulin Compared with Neutral Protamine Hagedorn Insulin in Patients with Type 2 Diabetes not Controlled with Oral Hypoglycemics: A Cohort Study
by: Ebtihal Bilal, et al.
Published: (2023-08-01)

Metabolicheskie osobennosti sindroma polikistoznykh yaichnikov u zhenshchin s normal'noy i izbytochnoy massoy tela
by: T A Zykova, et al.
Published: (2003-03-01)

The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial
by: Xiangyang Liu, et al.
Published: (2024-02-01)

Budget impact analysis of insulin glargine vs. isophane protamine insulin treatment for patients with type-2 diabetes and severe hypoglycemia in Thailand
by: Unchalee Permsuwan, et al.
Published: (2025-01-01)

Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
by: Jae Hyun Bae, et al.
Published: (2022-01-01)

Mozhno li dostignut' effektivnogo glikemicheskogo kontrolya sakharnogo diabeta 2 tipa: preimushchestva rannego naznacheniya insulina
by: Elena Valer'evna Biryukova
Published: (2008-03-01)

New strategies of insulin therapy - a way to effective glycemic control of type 2 diabetes mellitus
by: Elena Valer'evna Biryukova
Published: (2009-12-01)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
by: Elena Valer'evna Biryukova
Published: (2011-12-01)